Status:
UNKNOWN
Ultrasound-assessed Internal Jugular Vein Distensibility in Advanced Chronic Heart Failure (US-IJVD in CHF)
Lead Sponsor:
Niguarda Hospital
Conditions:
Systolic Chronic Heart Failure
Congestion, Venous
Eligibility:
All Genders
18+ years
Brief Summary
Prospective validation of the ultrasound-assessed internal jugular vein distensibility (JVD) ratio to identify patients with systolic chronic heart failure and right atrial pressure (RAP) of 7 or less...
Detailed Description
Peripheral congestion is caused by an excess of fluid in tissues and vessels. Fluid overload is associated with poor outcome in heart failure (HF)(1). Several clinical signs can suggest peripheral con...
Eligibility Criteria
Inclusion
- All patients with systolic chronic heart failure defined by a left ventricular ejection fraction (LVEF) \<50% on echocardiogram that, undergo elective RHC in the heart transplant/left ventricular assist device work-up.
- In case of occlusion of the left internal jugular vein (IJV), the RHC is performed from to contralateral IJV, and US-assessed JVD ratio will be measured on the right IJV.
Exclusion
- Patients supported by a left ventricular assist device.
- Patients with acute heart failure that undergo RHC as an urgent procedure in hemodynamically unstable patients.
- Patients unable/unwilling to sign a written informed consent.
- Patients in which an RHC is not feasible from an internal jugular vein.
Key Trial Info
Start Date :
October 18 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03874312
Start Date
October 18 2017
End Date
December 31 2022
Last Update
March 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
De Gasperis Cardio Center, Niguarda Hospital
Milan, Lombardy, Italy, 20162